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Abstract 
 
The resonance Raman spectra of the hydroperoxo complex of camphor-bound 
CYP101 have been obtained by cryoradiolytic reduction of the oxygenated 
ferrous form that had been rapidly frozen in water/glycerol frozen solution; 
EPR spectroscopy was employed to confirm the identity of the trapped 
intermediate. The ν(O−O) mode, appearing at 799 cm-1, is observed for the 
first time in a peroxo-heme adduct. It is assigned unambiguously by 
employing isotopomeric mixtures of oxygen gas containing 50% 16O18O, 
confirming the presence of an intact O−O fragment. The ν(Fe−O) mode is 
observed at 559 cm-1 (H2O). Furthermore, both modes shift down by 3 cm-1, 
documenting the formulation as a hydroperoxo complex, in agreement with 
EPR data.  
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The cytochromes P450 heme-thiolate enzymes facilitate quite 
difficult chemical transformations through a multistep reaction cycle 
that culminates in the generation of a remarkably potent oxidizing 
species capable of hydroxylating even inert substrates.1-3 Following 
substrate binding to the resting state ferric enzyme, two sequential 
one-electron reductions bracketing the binding of molecular oxygen 
and a subsequent proton delivery step lead to heterolytic O−O bond 
cleavage and formation of a highly reactive ferryl heme species 
comparable to the so-called Compound I intermediate of peroxidases.4-
6 Thus, key precursors to this critical cleavage reaction are activated 
heme-bound peroxo and hydroperoxo fragments; that is, 
(protoporphyrin)Fe(III)(O22-) or Fe(III)(O−OH-). A useful approach to 
access and study these species is to generate and trap the relatively 
stable oxy-ferrous P450 complex and then to subject the cryotrapped 
(77 K) sample to radiolytic reduction using radiation from synchrotron, 
60Co γ-ray, or 32P sources.7,8 Enzymatic intermediates produced by 
cryoradiolytic reduction of the oxygenated complex of cytochrome 
P450cam (CYP101) have been detected by both electronic absorption 
and EPR spectroscopic methods.7,9,10 However, critical mechanistic 
information has been missing, and it is now important to attempt to 
provide more detailed structural characterization of the active sites of 
these species.  
 
Resonance Raman (RR) spectroscopy is an especially attractive 
probe of such species, effectively interrogating both the heme 
macrocycle structure and various iron−ligand fragments.11-15 In fact, 
the feasibility of coupling this powerful spectroscopic probe with 
cryogenic radiolysis of heme protein samples was recently 
demonstrated and suggested to be a promising new approach to 
structurally characterize these important intermediates.3,14,15 The 
present work uses RR to provide the first direct observation of the 
structure-sensitive internal vibrational modes of the (Fe−OOH) 
fragment of the hydroperoxo−ferric intermediate of the CYP101 
enzyme.  
 
Samples of the oxygenated form of CYP101 were prepared by 
bubbling dioxygen gas through 30% glycerol/buffer solutions of the 
(ferrous) enzyme contained in 5 mm NMR tubes. The tube was shaken 
for several seconds to ensure efficient mixing and quickly frozen in 
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liquid nitrogen. The RR spectra of these trapped O2 adducts are 
entirely consistent with those published previously,16-18 with some 
slight shifts to higher frequency being due to low-temperature effects. 
The spectrum of the 16O2-ligated form, shown in trace A of Figure 1, 
exhibits the strong ν(16O−16O) band at 1139 cm-1, as expected.16-18 
Trace B shows the difference spectrum obtained by subtraction of the 
spectra of the 18O2 and 16O2 samples, while trace C shows the 
difference spectrum observed for the 16O2/H2O and 16O2/D2O samples, 
the latter confirming the lack of a shift for these dioxygen-ligated 
forms in D2O buffers, also as expected.16-18 The above RR spectral data 
confirm the integrity of the samples of O2 adducts. For reasons 
described below, it was decided to include samples prepared from so-
called “scrambled” mixtures of O2 isotopomers, such as [1:2:1] 
mixtures of [16O2:16O18O:18O2]. These mixtures were prepared as 
described elsewhere.19 Thus, trace D exhibits a spectral pattern 
expected for that of the 16O2 -ligated species subtracted from that of 
the adduct formed from the scrambled isotopic mixture, the negative 
peak in the region of the ν(16O−16O) resulting from combination of 
positive and negative ν(16O−16O) features in a 1:4 ratio; that is, the 
scrambled mixture contains only 25% 16O2. Similarly, trace E exhibits 
the expected pattern for the difference spectrum indicated.  
 
 
Figure 1 Left panel:  RR spectrum of 16O2 CYP101 in 30% glycerol/buffer 
before irradiation (A); 16O2−18O2 in glycerol/buffer (B); 16O2−18O2 in 
deuterated glycerol/buffer (C); scrambled 16O2 in glycerol/buffer (D); 
scrambled 18O2 in deuterated glycerol/buffer (E). Right panel:  RR spectrum of 
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16O2 CYP101 in 30% glycerol/buffer after irradiation (F); 16O2−18O2 in 
glycerol/buffer (G); 16O2−18O2 in deuterated glycerol/buffer (H); scrambled 
16O2 in glycerol/buffer (I); scrambled 18O2 in deuterated glycerol/buffer (J). 
Dashed line in trace A is for the sample with scrambled oxygen. 
These samples also exhibit the features expected for the 
ν(Fe−16O) and ν(Fe−18O) modes of the Fe−O2 fragments (Supporting 
Information, Figure S1), showing a positive feature at 546 cm-1 for the 
former and at 515 cm-1 for the latter, frequencies near those 
previously observed for these adducts in solution at 4 °C.17,18 It is also 
noted that these lowered frequencies, relative to corresponding values 
observed near 570 cm-1 for hemoglobin and myoglobin, are also 
consistent with expectations based on consideration of the trans-axial 
ligand effects, as has been carefully considered by Babcock and co-
workers.20  
 
These frozen oxygenated samples were then irradiated with a 
60Co γ-source to produce the reduced hydroperoxo forms; the EPR 
spectra confirmed the conversion with approximately 60% yield 
(Figure S2). The RR spectra were acquired using the 442 nm excitation 
line, a wavelength in closer resonance with the Soret band of the 
hydroperoxo form.9 We note that attempts to acquire the RR spectra of 
the reduced (i.e., hydroperoxo) form with the 413 nm excitation 
yielded only the spectral lines of residual O2 adducts.  
 
The RR spectra acquired for the γ-irradiated samples are shown 
in traces F−J. In trace F, it is seen that there are multiple resonance-
enhanced heme modes in this region; in fact, casual inspection of the 
absolute spectra in this spectral region provides no clear indication of 
modes associated with the Fe−O−O fragment of a peroxo formulation. 
However, as can be seen in traces G−J, upon subtraction of the 
overlapping heme macrocycle modes, the 16O/18O difference features 
attributable to such a fragment are clearly evident; that is, the 40 cm-1 
shift indicated by the positive and negative components shown in trace 
G is entirely consistent with that expected for the ν(O−O) mode of an 
Fe−O−O fragment of a peroxo/hydroperoxo formulation.21-24 However, 
bands observed near this frequency region, which also exhibit 
comparable 16O/18O shifts, have also been observed for Fe(IV) O 
fragments in Compound I and Compound II derivatives of various 
heme proteins, and without additional experimental data, there might 
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be lingering ambiguity regarding the nature of the species observed in 
the present experiments.11-13  
 
A conclusive set of experiments is realized, however, by 
employing the scrambled isotopomeric mixture mentioned earlier; that 
is, the 1:2:1 mixture of (16O2:16O18O:18O2). Thus, the revealing 
patterns observed in traces I and J for the scrambled 16O2 and 
scrambled 18O2 difference traces, respectively, confirm the fact that 
the oxygen isotope-sensitive modes represent species with intact O−O 
fragments; these difference traces are consistent only with an 
Fe−O−O- fragment and not an Fe O fragment, for which only a two-
band difference pattern would be observed. Furthermore, comparison 
of difference traces G and H shows that both the ν(16O−16O) and the 
ν(18O−18O) modes, observed at 799 and 759 cm-1 in H2O solutions, 
shift down to 796 and 755 cm-1, respectively, in deuterated glycerol 
buffers. These shifts are quite comparable to those observed for other 
M−OOH(D) fragments, supporting the formulation of this intermediate 
as a hydroperoxo species.21-24  
 
As is shown in Supporting Information (Figure S3), the low-
frequency spectra also exhibit new 16O/18O isotopic-sensitive bands at 
559/532 cm-1 that are most reasonably assigned to the ν(Fe−O) 
modes of an Fe−OOH(D) fragment, based on a 3 cm-1 shift in D2O and 
comparisons with other such species.14,15 Thus, the present results 
indicate that the ν(Fe−O) bond is stronger for the hydroperoxo species 
relative to the nonreduced oxy complex, based on a shift of 13 cm-1 to 
higher frequency. This shift is somewhat smaller, however, than the 
∼45 cm-1 shift observed for hydroperoxo myoglobin, relative to oxy 
myoglobin.14  
 
This observation of a trapped hydroperoxo form is quite 
consistent with behavior expected for the native cytochrome P450cam 
enzyme, which has previously been shown to proceed directly at 77 K 
to the hydroperoxo form, with rather small fractions of the 
unprotonated species (Fe−OO-) being present in the preparations.7 
Similarly, recent crystallographic studies of cryotrapped CPO 
Compound III also were interpreted to lead to radiation-induced 
conversion to the hydroperoxo form, with no evidence for a trapped 
peroxo-ligated species.25 Future studies with mutant proteins that 
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restrict proton delivery to the Fe−O−O fragment and may facilitate 
systematic comparisons between oxygenated, peroxo, and 
hydroperoxo forms, are planned. Finally, the successful stabilization 
and structural characterization of these immediate precursors to the 
reactive products formed from O−O bond cleavage may possibly lead 
to an effective strategy to structurally characterize fleeting 
intermediates that appear later in the cycle.1-6  
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